Home > Products > CD89 & EGFR
> Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (IgG(L)-scFv)
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (IgG(L)-scFv) (CAT#: IGLFV-132)
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (IgG(L)-scFv) is formed by an IgG and two scFv moieties. The scFv fragments from an anti-CD89 antibody are fused to the C terminus of an anti-EGFR IgG light (L) chains, or vice versa. It is a type of appended IgGs, which is bispecific and tetravalent (2+2 antigen-binding valency). This BsAb can retarget macrophages to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Non-small cell lung cancer (NSCLC); Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (IgG(L)-scFv) (IGLFV-132). Click the button below to contact us or submit your feedback about this product.